Latest Insider Transactions at Volitionrx LTD (VNRX)
This section provides a real-time view of insider transactions for Volitionrx LTD (VNRX). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of VOLITIONRX LTD to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of VOLITIONRX LTD's insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Oct 04
2022
|
Michel Gaetan Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+42.74%
|
-
|
|
Oct 04
2022
|
Michel Gaetan Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,883
-16.84%
|
$6,883
$1.46 P/Share
|
|
Oct 04
2022
|
Terig Hughes Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
100,000
+43.34%
|
-
|
|
Oct 04
2022
|
Martin Charles Faulkes Executive Director |
BUY
Grant, award, or other acquisition
|
Direct |
50,000
+3.08%
|
-
|
|
Sep 19
2022
|
Jacob Vincent Micallef Chief Scientific Officer |
BUY
Open market or private purchase
|
Indirect |
13,000
+27.08%
|
$13,000
$1.7 P/Share
|
|
Aug 30
2022
|
Cameron John Reynolds President and CEO |
BUY
Open market or private purchase
|
Direct |
3,500
+0.29%
|
$3,500
$1.61 P/Share
|
|
Aug 26
2022
|
Jacob Vincent Micallef Chief Scientific Officer |
BUY
Open market or private purchase
|
Direct |
29,000
+16.27%
|
$29,000
$1.74 P/Share
|
|
Aug 23
2022
|
Salvatore Thomas Butera CEO, Volition Veterinary |
BUY
Open market or private purchase
|
Direct |
5,000
+2.94%
|
$5,000
$1.6 P/Share
|
|
Aug 22
2022
|
Salvatore Thomas Butera CEO, Volition Veterinary |
BUY
Open market or private purchase
|
Direct |
5,000
+3.03%
|
$5,000
$1.64 P/Share
|
|
Aug 15
2022
|
Mickie Henshall |
BUY
Grant, award, or other acquisition
|
Direct |
15,000
+50.0%
|
-
|
|
Aug 03
2022
|
Jason Bradley Md Terrell Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Indirect |
404
-14.8%
|
$404
$1.97 P/Share
|
|
Aug 03
2022
|
Jason Bradley Md Terrell Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,279
-12.18%
|
$4,279
$1.97 P/Share
|
|
Aug 03
2022
|
Jacob Vincent Micallef Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,825
-3.86%
|
$4,825
$1.97 P/Share
|
|
Aug 03
2022
|
Gael Forterre Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,598
-5.22%
|
$3,598
$1.97 P/Share
|
|
Aug 03
2022
|
Martin Charles Faulkes Executive Director |
SELL
Payment of exercise price or tax liability
|
Direct |
4,825
-0.32%
|
$4,825
$1.97 P/Share
|
|
Aug 02
2022
|
Guy Archibald Innes |
BUY
Open market or private purchase
|
Indirect |
300,000
+50.0%
|
$600,000
$2.0 P/Share
|
|
Aug 02
2022
|
Guy Archibald Innes |
BUY
Open market or private purchase
|
Direct |
12,500
+0.79%
|
$25,000
$2.0 P/Share
|
|
Jun 23
2022
|
Terig Hughes Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
19,981
+39.39%
|
-
|
|
Jun 23
2022
|
Alan Colman |
BUY
Grant, award, or other acquisition
|
Direct |
4,569
+2.72%
|
-
|
|
Jun 23
2022
|
Martin Charles Faulkes Executive Director |
BUY
Grant, award, or other acquisition
|
Direct |
15,682
+1.01%
|
-
|
|
Jun 23
2022
|
Rodney Gerard Rootsaert Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
13,068
+24.39%
|
-
|
|
Jun 23
2022
|
Jason Bradley Md Terrell Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Indirect |
1,775
+39.4%
|
-
|
|
Jun 23
2022
|
Jason Bradley Md Terrell Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
22,845
+39.39%
|
-
|
|
Jun 23
2022
|
Gael Forterre Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,308
+16.17%
|
-
|
|
Jun 23
2022
|
Jasmine Kway CEO, Singapore Volition |
BUY
Grant, award, or other acquisition
|
Direct |
17,836
+39.39%
|
-
|
|
Jun 23
2022
|
Phillip Barnes |
BUY
Grant, award, or other acquisition
|
Direct |
3,046
+39.39%
|
-
|
|
Jun 23
2022
|
Michel Gaetan Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
25,876
+38.76%
|
-
|
|
Jun 23
2022
|
Jacob Vincent Micallef Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
15,682
+11.14%
|
-
|
|
Jun 23
2022
|
Cameron John Reynolds President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
32,270
+2.64%
|
-
|
|
Jun 23
2022
|
Guy Archibald Innes |
BUY
Grant, award, or other acquisition
|
Direct |
3,046
+0.2%
|
-
|
|
Jun 23
2022
|
Edward Futcher |
BUY
Grant, award, or other acquisition
|
Direct |
3,046
+6.62%
|
-
|
|
Jun 23
2022
|
Kim Nguyen |
BUY
Grant, award, or other acquisition
|
Direct |
3,046
+12.07%
|
-
|
|
Jun 23
2022
|
Richard Brudnick |
BUY
Grant, award, or other acquisition
|
Direct |
3,046
+13.4%
|
-
|
|
Jun 16
2022
|
Salvatore Thomas Butera CEO, Volition Veterinary |
BUY
Open market or private purchase
|
Direct |
10,000
+6.06%
|
$20,000
$2.05 P/Share
|
|
Jun 06
2022
|
Jason Bradley Md Terrell Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
14,949
-54.86%
|
$29,898
$2.47 P/Share
|
|
May 16
2022
|
Guy Archibald Innes |
BUY
Open market or private purchase
|
Direct |
10,000
+0.64%
|
$20,000
$2.37 P/Share
|
|
May 01
2022
|
Salvatore Thomas Butera CEO, Volition Veterinary |
SELL
Payment of exercise price or tax liability
|
Direct |
15,000
-9.38%
|
$30,000
$2.79 P/Share
|
|
Apr 11
2022
|
Jason Bradley Md Terrell Chief Medical Officer |
SELL
Open market or private sale
|
Direct |
10,000
-26.85%
|
$20,000
$2.75 P/Share
|
|
Apr 07
2022
|
Jasmine Kway CEO, Singapore Volition |
BUY
Grant, award, or other acquisition
|
Direct |
9,604
+50.0%
|
-
|
|
Apr 07
2022
|
Michel Gaetan Chief Operating Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,933
+48.15%
|
-
|
|
Apr 07
2022
|
Guy Archibald Innes |
BUY
Grant, award, or other acquisition
|
Direct |
1,640
+0.11%
|
-
|
|
Apr 07
2022
|
Jason Bradley Md Terrell Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Indirect |
955
+50.0%
|
-
|
|
Apr 07
2022
|
Jason Bradley Md Terrell Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
12,300
+24.82%
|
-
|
|
Apr 07
2022
|
Richard Brudnick |
BUY
Grant, award, or other acquisition
|
Direct |
1,640
+8.97%
|
-
|
|
Apr 07
2022
|
Rodney Gerard Rootsaert Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
7,036
+20.41%
|
-
|
|
Apr 07
2022
|
Phillip Barnes |
BUY
Grant, award, or other acquisition
|
Direct |
1,640
+50.0%
|
-
|
|
Apr 07
2022
|
Kim Nguyen |
BUY
Grant, award, or other acquisition
|
Direct |
1,640
+7.89%
|
-
|
|
Apr 07
2022
|
Jacob Vincent Micallef Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
8,443
+7.17%
|
-
|
|
Apr 07
2022
|
Alan Colman |
BUY
Grant, award, or other acquisition
|
Direct |
2,460
+1.53%
|
-
|
|
Apr 07
2022
|
Gael Forterre Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
7,165
+11.4%
|
-
|